OZEMPIC and different related medicines used to battle diabetes accounted for the one largest medical expenditure in Spain’s public well being system in 2024.
Ministry of Well being knowledge confirmed that Ozempic and associated semaglutide medication accounted or simply over €400m final 12 months.
The entire funds for medicines was €13.8 billion- up by 4.9% on 2023.
READ MORE:

Expenditure on Ozempic rose by 78% in 2021, 44.5% in 2022 and 42% in 2023.
Although the product has seen gross sales skyrocket worldwide to its effectiveness in opposition to weight problems, is just not prescribed in Spain’s public well being system for weight reduction.
Essentially the most consumed treatment final 12 months was paracetamol with the ache aid and fever-reducing drug promoting 60.3 million publicly-funded packages.
The second most prescribed drug was the antacid and gastric protector Omeprazole, with 49.1 million containers, adopted by the analgesic Metamizole, with 29.7 million packages.
Final 12 months, 1,269 new medication had been integrated into public funding, with an annual improve of 46%.
In 2024, 118 new lively substances had been accredited for prescription, of which 39 have orphan drug designation which is meant for the remedy or prognosis of
Three new superior therapies had been additionally integrated into official funding, together with gene and cell remedy therapies.
Spain’s well being system has 22,557 funded drug shows, which represents 68.4% of the medication authorised in Spain.
Virtually six out of ten of the merchandise on the list- 57.6%- are generic medication, reinforcing the position of those cheaper medication within the effectivity of the system.
The Ministry of Well being report additionally reveals that Spain has a really excessive protection of pharmacies, with 22,207 workplaces.
Final 12 months, there was a median of 1 pharmacy for each 2,189 residents.
Click on right here to learn extra Well being Information from The Olive Press.
Costa News Spain Breaking News | English News in Spain.